文献速递心力衰竭与心肌病

血管性血友病因子通过形成中性粒细胞胞外诱捕网加重心力衰竭

Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps.
PubMed 文献 · Eur Heart J · 2024-01-01

该研究探讨VWF-SLC44A2-NET轴在心力衰竭(HF)中的作用。在HF患者和TAC小鼠模型中观察到NET水平升高,PAD4敲除和NET抑制剂改善心功能。机制上,NETs通过NE-TLR4抑制PGC-1α导致心肌细胞线粒体功能障碍,VWF/ADAMTS13通过SLC44A2调控NET形成,沙库巴曲/缬沙坦增强该轴阻断的心脏保护效应。

要点

  • HF患者和TAC小鼠中NET水平升高,PAD4敲除或NET抑制剂可改善心功能。
  • NETs通过NE-TLR4抑制PGC-1α导致心肌细胞线粒体功能障碍和凋亡。
  • VWF/ADAMTS13通过SLC44A2调控NET形成,靶向该轴可能治疗HF。

核心结论

  • VWF-SLC44A2-NET轴调控线粒体稳态和功能,导致心肌凋亡并参与HF发病,靶向该轴可能成为HF治疗新策略。

研究设计与样本

  • 在HF患者和TAC小鼠HF模型中检测NET水平;使用PAD4敲除小鼠和NET抑制剂(GSK-484、DNase I、NEi)评估NETs在HF中的作用;通过RNA测序探究下游机制;使用rhADAMTS13、ADAMTS13和SLC44A2敲除鉴定NETs上游因子。

主要发现

  • HF患者和TAC小鼠HF模型中NET水平升高。
  • PAD4敲除和NET抑制剂改善心脏功能。
  • NETs通过NE-TLR4介导的PGC-1α抑制诱导线粒体功能障碍,抑制线粒体生物发生。
  • VWF/ADAMTS13通过SLC44A2调控NET形成。
  • 沙库巴曲/缬沙坦增强VWF-SLC44A2-NET轴阻断的心脏保护效应。

临床怎么用

  • 靶向VWF-SLC44A2-NET轴可能作为HF的潜在治疗途径,沙库巴曲/缬沙坦或可增强该轴阻断的心脏保护作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Heart failure (HF) is a leading cause of mortality worldwide and characterized by significant co-morbidities and dismal prognosis. Neutrophil extracellular traps (NETs) aggravate inflammation in various cardiovascular diseases; however, their function and mechanism of action in HF pathogenesis remain underexplored. This study aimed to investigate the involvement of a novel VWF-SLC44A2-NET axis in HF progression. METHODS: NET levels were examined in patients with HF and mouse models of transverse aortic constriction (TAC) HF. PAD4 knockout mice and NET inhibitors (GSK-484, DNase I, NEi) were used to evaluate the role of NETs in HF. RNA sequencing was used to investigate the downstream mechanisms. Recombinant human ADAMTS13 (rhADAMTS13), ADAMTS13, and SLC44A2 knockouts were used to identify novel upstream factors of NETs. RESULTS: Elevated NET levels were observed in patients with HF and TAC mouse models of HF. PAD4 knockout and NET inhibitors improved the cardiac function. Mechanistically, NETs induced mitochondrial dysfunction in cardiomyocytes, inhibiting mitochondrial biogenesis via the NE-TLR4-mediated suppression of PGC-1α. Furthermore, VWF/ADAMTS13 regulated NET formation via SLC44A2. Additionally, sacubitril/valsartan amplifies the cardioprotective effects of the VWF-SLC44A2-NET axis blockade. CONCLUSIONS: This study established the role of a novel VWF-SLC44A2-NET axis in regulating mitochondrial homeostasis and function, leading to cardiac apoptosis and contributing to HF pathogenesis. Targeting this axis may offer a potential therapeutic approach for HF treatment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Mang, Chen, Sun, et al. Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps. Eur Heart J. 2024. PMID: 39165142. doi:10.1093/eurheartj/ehae517

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。